Appendix C
Workshop on Integrating Findings Across Domains of Influence

AGENDA

December 14, 2009

8:45 am

Welcome and Overview of the Day

Rosemary Chalk, Director, Board on Children, Youth, and Families

 

Laurence Steinberg, Ph.D., Temple University (Committee Chair)

9:00 am

Adolescent Behavior, Risk-Taking, and Public Policy

 

J. David Hawkins, Ph.D., University of Washington

 

Kathryn Monahan, Ph.D., University of Washington

 

Harold Holder, Ph.D., Prevention Research Center of the Pacific Institute for Research and Evaluation

 

  • What is known about the nature and scope of co-occurring problems in adolescent risk behavior?

  • What is known about the developmental specificity of this covariation?



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 126
Appendix C Workshop on Integrating Findings Across Domains of Influence AGENDA December 14, 2009 8:45 am Welcome and Overview of the Day Rosemary Chalk, Director, Board on Children, Youth, and Families Laurence Steinberg, Ph.D., Temple University (Committee Chair) 9:00 am Adolescent Behavior, Risk-Taking, and Public Policy J. David Hawkins, Ph.D., University of Washington Kathryn Monahan, Ph.D., University of Washington Harold Holder, Ph.D., Prevention Research Center of the Pacific Institute for Research and Evaluation • What is known about the nature and scope of co- occurring problems in adolescent risk behavior? • What is known about the developmental specificity of this covariation? 

OCR for page 126
 APPENDIX C • How can broad-scale public policy prevent adoles- cent risk behavior? Committee Discussants Laurie Chassin, Ph.D., Arizona State University Robert Wm. Blum, M.D., M.P.H., Ph.D., Johns Hopkins University Discussion and Q & A 10:00 am The Biology of Adolescent Risk Behavior Linda Patia Spear, Ph.D., Binghamton University • How is our understanding of adolescent behav- ior informed by consideration of the biology of adolescence? • To what extent and in what ways is risky behavior biologically driven, and how does consideration of the biology of adolescent development inform our understanding of adolescent risk behavior, individual differences in these behaviors, and their consequences? Committee Discussants B. J. Casey, Ph.D., Weill Medical College of Cornell University Daniel S. Pine, M.D., National Institute of Mental Health Elizabeth J. Susman, Ph.D., The Pennsylvania State University Discussion and Q & A 11:00 am Contextual Influences on Adolescent Risk Behavior Family and Peers Kenneth A. Dodge, Ph.D., Duke University Nancy A. Gonzales, Ph.D., Arizona State University School Stephanie Jones, Ph.D., Harvard Graduate School of Education Community Deborah Gorman-Smith, Ph.D., Chapin Hall at the University of Chicago

OCR for page 126
 THE SCIENCE OF ADOLESCENT RISK-TAKING Mass Media Blair Johnson, Ph.D., The University of Connecticut • What key mechanisms or features of these influ- ences uniquely affect adolescent risk behavior? • Can changes in certain contextual factors in these contexts reduce or prevent risky behavior? • What are the most salient proximal and distal factors in these contexts that affect risk taking in adolescence? Committee Discussants B. Bradford Brown, Ph.D., University of Wisconsin James J. Jaccard, Ph.D., Florida International University Marc A. Zimmerman, Ph.D., University of Michigan Discussion and Q & A 1:45 pm Discussion: Integration in the Science of Adolescence Committee Facilitators Laurence Steinberg Marc A. Zimmerman, Ph.D., University of Michigan • What overarching lessons about the genesis of risky behavior in adolescence can be gleaned from the morning’s presentations? How can we integrate knowledge across levels and domains of influence? • What are important next steps in the science agenda? What is not known and needs to be known? Should our approach to the study of ado- lescent risk behavior change, and if so, in what ways? • What are the implications of what has been pre- sented today for interventions? Discussion and Q & A 3:30 pm Closing Remarks and Next Steps Laurence Steinberg Jennifer Appleton Gootman, Board on Children, Youth, and Families (Study Director) 4:00 pm Adjourn

OCR for page 126
 APPENDIX C PARTICIPANTS Tasha Akitobi, National Association of County and City Health Officials Trina Anglin, Maternal and Child Health Bureau/Health Resources and Administration, Office of Adolescent Health, U.S. Department of Health and Human Services (HHS) Ariel Babinsky, Columbia University Jon Berg, Pal-Tech, Inc. Cheryl Anne Boyce, Division of Clinical Neuroscience and Behaviorial Research, National Institute on Drug Abuse, National Institutes of Health (NIH) Barbara Broman, Office of the Assistant Secretary for Planning and Evaluation, (HHS) Seth Chamberlain, Administration for Children and Families, HHS Stan Chappell, Family and Youth Services Bureau, Administration for Children and Families, HHS Kevin Conway, Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, NIH Max Crowley, The Pennsylvania State University Ronald E. Dahl, Psychiatry and Pediatrics, Department of Psychology, School of Medicine, University of Pittsburgh Jamie Davis, Altarum Institute Robert Denniston, National Youth Anti-Drug Media Campaign, Office of National Drug Control Policy Kathy Etz, Epidemiology Research Branch, National Institute on Drug Abuse, NIH Joseph Frascella, National Institute on Drug Abuse, NIH Robert Freeman, Division of Epidemiology and Prevention Research, National Institute on Alcohol Abuse and Alcoholism, NIH Miryam Gerdine, Office of Minority Health, NIH Lisa Hill, Department of Psychology, Hampton University Sarah Lindstrom Johnson, Schools of Medicine and Public Health, Johns Hopkins University Dionne Jones, National Institute on Drug Abuse, NIH Jennifer Joseph, National Association of County and City Health Officials Evelyn Kappeler, Office of Population Affairs, HHS Mariana Kastrinakis, Earth Institute, Columbia University Meredith Kelsey, Abt Associates, Inc. Elisa Klein, Office of Behavioral and Social Sciences Research, NIH Stan Koutstaal, Division of Abstinence Education, Administration for Children and Families, HHS Nona Lu, National Institute of Drug Abuse, NIH

OCR for page 126
0 THE SCIENCE OF ADOLESCENT RISK-TAKING Valerie Maholmes, Child Development and Behavior Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH Aleta Meyer, National Institute on Drug Abuse, NIH Martha Moorehouse, Office of the Assistant Secretary for Planning and Evaluation, HHS Wendy Nilsen, Office of Behavioral and Social Sciences Research, NIH Sarah Oberlander, U.S. Department of Health and Human Services Ronne Ostby, White House Office of National Drug Control Policy Eleanor Ott, Office of Planning, Research and Evaluation Bureau, Administration for Children and Families, HHS Sarah Potter, Office of Human Services Policy, Office of the Assistant Secretary for Planning and Evaluation, HHS LeShawndra Price, Epidemiology Research Branch, National Institute on Drug Abuse, NIH Eve Reider, Prevention Research Branch, National Institute on Drug Abuse, NIH Tracy Rone, Institute for Urban Research, Morgan State University Deborah Rose, Administration for Children and Families, HHS Angela Sharpe, Consortium of Social Science Associations Mariela Shirley, Division of Epidemiology and Prevention Research, National Institute on Alcohol Abuse and Alcoholism, NIH Karen Sirocco, Division of Clinical Neuroscience and Behavioral Research, National Insitute on Drug Abuse, NIH Lillian Sowah, Family and Youth Services Bureau, Administration for Children and Families, HHS L. R. Stanford, Division of Clinical Neuroscience and Behavioral Research, National Institute on Drug Abuse, NIH Katy Suellentrop, National Campaign to Prevent Teen and Unplanned Pregnancy Lisa Trivits, Office of the Assistant Secretary for Planning and Evaluation, HHS Diana Tyson, Office of the Assistant Secretary for Planning and Evaluation, HHS Aaron White, National Institute of Alcohol Abuse and Alcoholism, NIH